Section Arrow
NYXH.NASDAQ
- Nyxoah SA
Quotes are at least 15-min delayed:2025/11/14 23:09 EST
Regular Hours
Last
 5
-0.31 (-5.84%)
Day High 
5.25 
Prev. Close
5.31 
1-M High
6.2034 
Volume 
64.19K 
Bid
4.95
Ask
5.19
Day Low
4.74 
Open
4.75 
1-M Low
4.8 
Market Cap 
199.36M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.25 
20-SMA 5.37 
50-SMA 5.36 
52-W High 11.87 
52-W Low 4.345 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.12/-3.40
Enterprise Value
220.65M
Balance Sheet
Book Value Per Share
2.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.35M
Operating Revenue Per Share
0.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed:2025/11/14 23:09 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.